探路者(300005.SZ)擬新增經營範圍“組織生產、銷售防護服,銷售醫療器械”
格隆匯2月19日丨探路者(300005.SZ)公佈,為響應國家應對疫情防治所需,結合市場需求及公司實際經營情況,公司充分發揮國家高新技術企業優勢,利用自身在相關領域的技術研發及生產組織能力,在相關部門的支持下將積極開展非醫用防護服等防護物資研發及組織生產,以實際行動支持新型冠狀病毒的防疫工作。為滿足業務開展需求,公司擬新增經營範圍“組織生產、銷售防護服,銷售醫療器械”,並將《公司章程》中有關條款加以修訂。同時因醫療器械的生產和銷售尚需在食品藥品監督管理部門完成相關備案註冊,公司的經營範圍、許可經營項目的最終變更內容將以食品藥品監督管理部門的備案註冊及工商登記機關核准的內容為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.